Litigation Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. LUPIN ATLANTIS HOLDINGS SA (D.N.J. 2018)
✉ Email this page to a colleague
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. LUPIN ATLANTIS HOLDINGS SA (D.N.J. 2018)
| Docket | ⤷ Start Trial | Date Filed | 2018-08-10 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 15:1126 Patent Infringement | Assigned To | |
| Jury Demand | Defendant | Referred To | |
| Parties | LUPIN ATLANTIS HOLDINGS SA | ||
| Patents | 7,070,800; 7,694,676 | ||
| Attorneys | KATHERINE ANN ESCANLAR | ||
| Firms | Saul Ewing Arnstein & Lehr LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. LUPIN ATLANTIS HOLDINGS SA
The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .
Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. LUPIN ATLANTIS HOLDINGS SA (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-08-10 | External link to document | |||
| 2018-08-10 | 1 | Complaint | United States Patent Nos. 7,070,800 (“the ’800 patent”) and 7,694,676 (“the ’676 patent”). This Court…expiration of United States Patent Nos. 7,070,800 and 7,694,676 (the “patents-in- suit”). Plaintiffs seek…Unenforceability, and/or Non-Infringement for U.S. Patent Nos. 7,070,800 B2 and 7,694,676 B2, (the “Notice Letter… US 7,070,800 B2 Bechtold-Peters et al. … US 7,070,800 B2 1. | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
